Monica Vaccari

Tulane University — United States

Immunology and Microbiology · Life Sciences

30h-index3.8kcitations93works5.82yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

HIV Research and Treatment(58), Immune Cell Function and Interaction(40), T-cell and B-cell Immunology(24), Immunotherapy and Immune Responses(13), SARS-CoV-2 and COVID-19 Research(8)

Publications93 total

Inflammation from mild COVID-19 results in persistent neurological and behavioral changes in rhesus macaques
2025Open Access
Publisher Correction: TGF-β blockade drives a transitional effector phenotype in T cells reversing SIV latency and decreasing SIV reservoirs in vivo
Nature Communications·2024· 1 citedOpen Access
Exploring HIV Vaccine Progress in the Pre-Clinical and Clinical Setting: From History to Future Prospects
Viruses·2024· 15 citedOpen Access
TGF-β blockade drives a transitional effector phenotype in T cells reversing SIV latency and decreasing SIV reservoirs in vivo
Nature Communications·2024· 10 citedOpen Access
Exploring HIV Vaccine Progress in Pre-clinical and Clinical Settings: From History to Future Prospects.
Preprints.org·2024· 3 citedOpen Access
In Vivo Treatment with Insulin-like Growth Factor 1 Reduces CCR5 Expression on Vaccine-Induced Activated CD4+ T-Cells
Vaccines·2023· 1 citedOpen Access
TGF-β blockade drives a transitional effector phenotype in T cells reversing SIV latency and decreasing SIV reservoirs <i>in vivo</i>
2023· 1 citedOpen Access
Modulation of type I interferon responses potently inhibits SARS-CoV-2 replication and inflammation in rhesus macaques
Science Immunology·2023· 27 citedOpen Access
Editorial: CD4+ T cells in HIV: A Friend or a Foe?
Frontiers in Immunology·2023· 10 citedOpen Access
HIV vaccine candidate efficacy in female macaques mediated by cAMP-dependent efferocytosis and V2-specific ADCC
Nature Communications·2023· 19 citedOpen Access
Modulation of type I interferon responses potently inhibits SARS-CoV-2 replication and inflammation in rhesus macaques
2022· 9 citedOpen Access
Blocking α <sub>4</sub> β <sub>7</sub> integrin delays viral rebound in SHIV <sub>SF162P3</sub> -infected macaques treated with anti-HIV broadly neutralizing antibodies
Science Translational Medicine·2021· 15 citedOpen Access
Table of Contents
American Journal Of Pathology·2021Open Access
Anti-V2 antibodies virus vulnerability revealed by envelope V1 deletion in HIV vaccine candidates
iScience·2021· 29 citedOpen Access
Cellular events of acute, resolving or progressive COVID-19 in SARS-CoV-2 infected non-human primates
Nature Communications·2020· 99 citedOpen Access
Acute Respiratory Distress in Aged, SARS-CoV-2–Infected African Green Monkeys but Not Rhesus Macaques
American Journal Of Pathology·2020· 147 citedOpen Access
Cellular events of acute, resolving or progressive COVID-19 in SARS-CoV-2 infected non-human primates
2020· 7 citedOpen Access
“Acute Respiratory Distress and Cytokine Storm in Aged, SARS-CoV-2 Infected African Green Monkeys, but not in Rhesus Macaques”
2020· 16 citedOpen Access
Correction: ALVAC-HIV B/C candidate HIV vaccine efficacy dependent on neutralization profile of challenge virus and adjuvant dose and type
PLoS Pathogens·2020· 15 citedOpen Access
Engagement of monocytes, NK cells, and CD4+ Th1 cells by ALVAC-SIV vaccination results in a decreased risk of SIVmac251 vaginal acquisition
PLoS Pathogens·2020· 21 citedOpen Access
page 1 of 5Next →

Frequent Co-authors

Genoveffa Franchini(35), David Venzon(23), Melvin N. Doster(18), David C. Montefiori(13), Shari N. Gordon(12), Luca Schifanella(11), Namal P. M. Liyanage(11), Adriano Boasso(10), Mangala Rao(10), Genoveffa Franchini(10), Mario Roederer(8), Brandon F. Keele(8), Georgia D. Tomaras(8), Poonam Pegu(8), Massimiliano Bissa(8), Marjorie Robert-Guroff(8), Anna Hryniewicz(8), Gene M. Shearer(7), Valentina Cecchinato(7), Xiaoying Shen(7)